Overexpression of lncRNA-XIST via miR-126/IRS1/PI3K/Akt pathway could enhance glucose metabolism in glioma. Knockdown of lncRNA-XIST could reduce GLUT1 and GLUT3 levels. This evidence concerns the gene SLC2A1 and central nervous system cancer.